Switch to:
More From Other Websites
Today's Market Thorns, Roses and All Time Highs... Sep 18 2014
Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies Sep 18 2014
The Market's Thorns, Roses, and All Time Highs... Sep 17 2014
Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for... Sep 17 2014
Source Looks to Bring Europe ETF Success to the U.S. Sep 16 2014
2 Solid Picks for a Weak Euro Sep 15 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 12 2014
Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada Sep 12 2014
Eli Lilly/Boehringer's Insulin Biosimilar Gains EU Approval Sep 11 2014
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received... Sep 11 2014
The Market's Thorns, Roses, and All Time Highs... Sep 10 2014
Receptos MS Drug Yields More Good Data; Stock Jumps Sep 10 2014
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected Sep 10 2014
Genzyme Announces Launch of “Expression of Hope III” Program to Build Awareness of Lysosomal... Sep 10 2014
Investment, Un-American Style Sep 10 2014
FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease Sep 08 2014
Why Illumina (ILMN) Stock Is Gaining Today Sep 08 2014
Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at... Sep 08 2014
[video] Regeneron Rises, Norwegian Cruises and CVS Health Quits the Habit Sep 04 2014
Today's Market Thorns, Roses, and All Time Highs Sep 04 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial